Sushil Patel

Director

Sushil Patel (Director) filed 4 Form 4 reports in the trailing twelve months (0 purchases, 4 sales), most often in Replimune Group, Inc. (REPL). The largest single filing was $919K of RVMD (4,880 sh across 6 lots, as filed), executed Jun 29.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 4 sells

Median delay

–

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$1.7M

shares × price, as filed

Last traded

Aug 10

Filed Aug 12

Median ADV $548.2M across their filed names

Open performance→

Volume by month

Buys $0 Sells $2.3M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 4 filings

Sector per market data · by filing · past 12 months

Most traded names

REPL

Replimune Group, Inc. REPL · 0 buys · 5 sells 5 filings RVMD

Revolution Medicines, Inc. RVMD · 0 buys · 2 sells 2 filings

Recent filings

REPLSALE Replimune Group, Inc. View filing → $510K
39,341 sh × $12.97
Exec Aug 10
Filed Aug 12 · 5:07 PM ET RVMDSALE Revolution Medicines, Inc. View filing → $919K
4,880 sh across 6 lots
Exec Jun 29
Filed Jul 1 · 6:25 PM ET REPLSALE Replimune Group, Inc. View filing → $190K
37,324 sh × $5.08
Exec May 18
Filed May 20 · 5:30 PM ET REPLSALE Replimune Group, Inc. View filing → $111K
10,000 sh × $11.13
Exec Dec 2 2025
Filed Dec 4 2025 · 5:30 PM ET REPLSALE Replimune Group, Inc. View filing → $202K
25,105 sh × $8.06
Exec May 20 2025
Filed May 22 2025 · 5:30 PM ET REPLSALE Replimune Group, Inc. View filing → $124K
10,000 sh × $12.42
Exec Dec 16 2024
Filed Dec 18 2024 · 5:30 PM ET RVMDSALE Revolution Medicines, Inc. View filing → $271K
5,000 sh × $54.14
Exec Oct 31 2024
Filed Nov 4 2024 · 5:30 PM ET